Champions Oncology Stock Target Price and Analyst Consensus
| CSBR Stock | USD 6.30 0.06 0.96% |
The current analyst and expert consensus on Champions Oncology is Strong Buy, with only one strong buy opinion. The current projected Champions Oncology target price consensus is 12.00 with 1 analyst opinions. Check out Macroaxis Advice on Champions Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.The most common way Champions Oncology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Champions Oncology executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Champions Oncology. We encourage you to use your own analysis of Champions Oncology to validate this buy or sell advice. Champions Oncology buy-or-sell recommendation module provides average expert sentiment on the projected Champions Oncology target price to derive its highest and lowest estimates based on projected price volatility of 5.644.
Lowest Forecast 10.92 | Highest Forecast 13.32 | Target Price 12 |
Champions | Build AI portfolio with Champions Stock |
It's important to approach Champions Oncology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Champions Oncology Target Price Consensus
Champions target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Champions Oncology's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most Champions analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Champions stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Champions Oncology, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationChampions Oncology Target Price Projection
Champions Oncology's current and average target prices are 6.30 and 12.00, respectively. The current price of Champions Oncology is the price at which Champions Oncology is currently trading. On the other hand, Champions Oncology's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Champions Oncology Market Quote on 29th of July 2025
Target Price
Analyst Consensus On Champions Oncology Target Price
Champions Oncology Analyst Ratings
Champions Oncology's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Champions Oncology stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Champions Oncology's financials, market performance, and future outlook by experienced professionals. Champions Oncology's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Champions Oncology price targets
Champions Oncology's stock target price is an estimate of its future price, usually made by analysts. Using Champions Oncology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Champions Oncology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Champions Oncology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Champions Oncology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Champions Oncology is a key component of Champions Oncology valuation and have some predictive power on the future returns of a Champions Oncology.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Asset Allocation ETFs Invested over 200 shares | |
| Strategy ETFs Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
| Single Stock ETFs Invested over 100 shares | |
 | Real Estate Invested over 100 shares | |
Additional Tools for Champions Stock Analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.